Alyeska Investment Group’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-530,893
Closed -$15.7M 380
2022
Q2
$15.7M Buy
530,893
+297,210
+127% +$9.99M 0.18% 164
2022
Q1
$9.53M Buy
+233,683
New +$10M 0.11% 214
2021
Q4
Sell
-419,454
Closed -$17.4M 596
2021
Q3
$17.4M Buy
419,454
+3,593
+0.9% +$143K 0.22% 127
2021
Q2
$18.8M Buy
+415,861
New +$19.5M 0.22% 135
2020
Q4
Sell
-111,930
Closed -$1.94M 500
2020
Q3
$1.94M Sell
111,930
-60,059
-35% -$1.05M 0.03% 358
2020
Q2
$2.82M Buy
+171,989
New +$2.62M 0.04% 331

Other funds holding ADNT

Alyeska Investment Group's ADNT Position: Q3 2022 in Review

Alyeska Investment Group sold out of Adient (ADNT) in Q3 2022, closing a stake of 530,893 shares — an estimated $15.7M sold.

Alyeska Investment Group first reported a position in ADNT in Q2 2020 and held it in 6 quarters. The position peaked at $18.8M in Q2 2021. 247 funds tracked by Wall St. Rank hold ADNT as of Q3 2022.

  • Alyeska Investment Group reported no remaining Adient position as of Q3 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 530,893 Adient shares in Q3 2022, an estimated $15.7M.
  • Alyeska Investment Group first reported a position in Adient in Q2 2020 and held it in 6 quarters.
  • Alyeska Investment Group's Adient position peaked at $18.8M in Q2 2021.
  • 247 funds tracked by Wall St. Rank held Adient as of Q3 2022.

Based on Alyeska Investment Group's 13F filing for Q3 2022, filed 14 Nov 2022.